Short-Term Outcomes of Three Consecutive Monthly Loading Administrations of Aflibercept 8 Mg for Treatment-Naïve Exudative Age-Related Macular Degeneration

Short-Term Outcomes of Three Consecutive Monthly Loading Administrations of Aflibercept 8 Mg for Treatment-Naïve Exudative Age-Related Macular Degeneration

<b>Background/Objectives:</b> The aim was to investigate the short-term outcomes of three consecutive monthly aflibercept 8 mg administrations for treatment-naïve eyes with exudative age-related macular degeneration (AMD). <b>Methods:</b> Twenty-one eyes with exudative AMD we...

Full description

Saved in:

Bibliographic Details
Main Authors:	Shuhei Hosoda, Yoichi Sakurada, Yoshiko Fukuda, Yumi Kotoda, Wataru Kikushima, Kenji Kashiwagi
Format:	Article
Language:	English
Published:	MDPI AG 2025-03-01
Series:	Pharmaceuticals
Subjects:	exudative age-related macular degeneration polypoidal choroidal vasculopathy aflibercept 8 mg short-term outcome
Online Access:	https://www.mdpi.com/1424-8247/18/3/438
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Spontaneous resolution of photodynamic therapy-induced acute exudative maculopathy in a patient suffering from polypoidal choroidal vasculopathy: A case report with 3-year follow-up
by: Alexandros Rouvas, et al.
Published: (2025-01-01)

Polypoidal Choroidal Vasculopathy Treatment: Photodynamic Therapy, Anti-VEGF Monotherapy or Combination. Review of Clinical Studies
by: E. K. Pedanova, et al.
Published: (2019-06-01)

Research status of clinicopathologic studies of polypoidal choroidal vasculopathy
by: LI Miaoling, et al.
Published: (2025-02-01)

A case of treating polypoidal choroidal vasculopathy subretinal fluid by subthreshold micropulse laser
by: Sarmad Mustafa Jafar, et al.
Published: (2024-12-01)

Comparison of one-year real-world outcomes between red (670 nm) subthreshold micropulse laser treatment and intravitreal aflibercept injection for treatment-naïve diabetic macular edema
by: Wataru Kikushima, et al.
Published: (2025-02-01)

Efficacy and Safety of Ophthalmic Steroids in the Management of Polypoidal Choroidal Vasculopathy: A Systematic Review
by: Adriono GA, et al.
Published: (2025-03-01)

Polypoidal choroidal vasculopathy with an exceptionally elevated pigment epithelial detachment
by: Yanliang Li, et al.
Published: (2024-12-01)

Analysis of cytokine profiles in aqueous humor based on optical coherence tomography in pachychoroid spectrum diseases
by: Caiyun Zhang, et al.
Published: (2025-07-01)

Clinical implication of aberrant choroidal feeding artery in type 1 macular neovasculopathy
by: Hyun Seung Yang, et al.
Published: (2025-05-01)

Pachychoroid Spectrum Disorders: A Review of Clinical Features and Management
by: Devesh Kumawat, et al.
Published: (2019-07-01)

Full-Thickness Macular Hole Formation After Intravitreal Faricimab Injection for Polypoidal Choroidal Vasculopathy
by: Tavonvunchai F, et al.
Published: (2025-06-01)

Post-typhoid fever exudative retinal detachment
by: Harshvardhan M Raghuwanshi, et al.
Published: (2025-07-01)

Impact of photodynamic therapy combined with Anti-VEGF vs. Anti-VEGF monotherapy on choriocapillaris vessel density in polypoidal choroidal vasculopathy
by: Po-Chin Kuo, et al.
Published: (2025-04-01)

Comparative outcomes of pars plana vitrectomy with subretinal rt-PA injection in polypoidal choroidal vasculopathy: the role of simultaneous anti-VEGF treatment
by: Lulu Chen, et al.
Published: (2025-07-01)

Effectiveness of aflibercept in treating bevacizumab resistant macular edema
by: Hussain Khudair Yassin
Published: (2024-12-01)

Transvitreal endoresection of peripheral exudative hemorrhagic chorioretinopathy: a clinicopathological study
by: Satoru Kase, et al.
Published: (2025-04-01)

Age-Related Scattered Hypofluorescent Spots as an Adverse Prognostic Factor for Polypoidal Choroidal Vasculopathy
by: Seo Hee Kim, MD, et al.
Published: (2025-09-01)

Switching to Faricimab for Polypoidal Choroidal Vasculopathy with Real-World Outcomes in Refractory Cases &ndash; The FAR-PEARL Study Report 1
by: Fong KC, et al.
Published: (2025-07-01)

Prognostic factors in the treatment of polypoidal choroidal vasculopathy with conbercept: a post hoc analysis of the STAR study
by: Tsung-I. Wang, et al.
Published: (2025-06-01)

12-month outcomes of ziv-aflibercept for neovascular age-related macular degeneration in eyes previously treated with aflibercept
by: Wajiha J Kheir, et al.
Published: (2025-01-01)

Multimodal imaging of tumour-related lipid exudation and exudative retinal detachment following brachytherapy in choroidal melanoma
by: Elena Ros-Sanchez, et al.
Published: (2025-08-01)

Clinical Response To Switch From Ranibizumab To Aflibercept In Wet Age-Related Macular Degeneration
by: Bhagya Weerasinghe, et al.
Published: (2021-01-01)

Efficacy of Aflibercept (8 mg) for Diabetic Macular Edema in Vitrectomized Eyes Refractory to the Other Anti-VEGF Drug Therapies: A Report of Three Cases
by: Kashiwagi I, et al.
Published: (2025-04-01)

Influence of Aflibercept on Choroidal Blood Flow and Thickness in Branch Retinal Vein Occlusion: A Six-Month Follow-Up Study
by: Ryuya Hashimoto, et al.
Published: (2024-11-01)

Bilateral improvement in age-related macular degeneration following unilateral Aflibercept injection
by: Muhammad Irfan Karamat, et al.
Published: (2024-12-01)

Treat and Extend Regimen of Aflibercept in the Treatment of Type 1 Choroidal Neovascularization Secondary to Chronic Central Serous Chorioretinopathy: Three-year Follow-Up
by: Kustryn TB, et al.
Published: (2025-07-01)

Influence of combined eplerenone, aflibercept and nepafenac therapy on central serous chorioretinopathy
by: Wael Ahmed Ewais, et al.
Published: (2025-06-01)

Efficacy of intravitreal injection of Ziv-aflibercept before vitrectomy for proliferative diabetic retinopathy
by: Amin E. Nawar, et al.
Published: (2024-04-01)

Experiences of using Aflibercept in diabetic macular edema treatment: data from routine clinical practice
by: E. Yu. Santoro
Published: (2018-12-01)

Uso de regorafenibe em pacientes com câncer colorretal metastático previamente tratados com bevacizumabe ou aflibercepte: experiência clínica uni-institucional
by: Rodrigo Nogueira Fogace, et al.
Published: (2017-10-01)

Transitioning from Aflibercept to Biosimilar Ranibizumab in Diabetic Macular Edema (DME): (The TRANSFORM-DME Trial) a Multicenter Observational Study
by: Chakraborty D, et al.
Published: (2024-11-01)

Efficacy and safety of intravitreal injection of aflibercept biosimilar for treating diabetic macular edema
by: Gaixia Zhai, et al.
Published: (2025-03-01)

Vitrectomy for full-thickness macular hole developed during aflibercept treatment for wet age-related macular degeneration
by: Agnieszka Nowosielska
Published: (2024-12-01)

Efficacy and Safety of Aflibercept Biosimilars Relative to Reference Aflibercept Therapy for Neovascular Age-Related Macular Degeneration: A Systematic Review and Meta-Analysis
by: Aljuhani HS, et al.
Published: (2025-06-01)

Efficacy of aflibercept combined with 80% dose photodynamic therapy for pachychoroid neovasculopathy
by: Norihiko Nakagawa, et al.
Published: (2025-07-01)

Corrigendum: Efficacy and safety of intravitreal injection of aflibercept biosimilar for treating diabetic macular edema
by: Gaixia Zhai, et al.
Published: (2025-05-01)

Non-Invasive Diagnosis of Polypoidal Choroidal Vasculopathy as a Variant of the Course of Age-Related Macular Degeneration
by: I. E. Panova, et al.
Published: (2018-07-01)

A New Anti-VEGF Inhibitor, Aflibercept: Treatment Outcomes Of Neovascular Macular Degeneration Refractory To Other Anti-VEGF Agents
by: Kiran Turaka
Published: (2014-04-01)

Pharmacoeconomic research of using aflibercept in patients with the wet age-related macular degeneration
by: S. V. Nedogoda, et al.
Published: (2020-03-01)

CYTOLOGICAL FEATURES OF FENSPIRIDE USAGE IN TREATMENT OF CHRONIC EXUDATIVE OTITIS MEDIA
by: O. Yu. Mezentseva, et al.
Published: (2012-03-01)